CONSOLIDATED STATEMENTS OF EARNINGS - USD ($) shares in Millions, $ in Millions		3 Months Ended		9 Months Ended
		Mar. 31, 2020	Mar. 31, 2019	Mar. 31, 2020	Mar. 31, 2019
Net Sales		$ 17,214	$ 16,462	$ 53,252	$ 50,590
Cost of Products Sold		8,716	8,427	26,308	25,830
Selling, General and Administrative Expense		5,045	4,806	14,719	14,081
Operating Income		3,453	3,229	12,225	10,679
Interest Expense		(100)	(131)	(308)	(398)
Interest Income		39	52	133	168
Other Non-operating Income/(Loss), Net		106	128	323	685
Earnings/(Loss) from Continuing Operations Before Income Taxes		3,498	3,278	12,373	11,134
Income Taxes on Continuing Operations		541	502	2,056	1,931
Net Earnings		2,957	2,776	10,317	9,203
Net Income (Loss) Attributable to Noncontrolling Interest		$ 40	$ 31	$ 90	$ 65
Basic Net Earnings Per Common Share
Basic Net Earnings Per Common Share	[1],[2]	$ 1.15	$ 1.07	$ 4.03	$ 3.58
Diluted Net Earnings Per Common Share
Diluted Net Earnings Per Common Share	[1],[2]	$ 1.12	$ 1.04	$ 3.89	$ 3.48
Diluted Weighted Average Common Shares Outstanding		2,613.3	2,637.7	2,630.3	2,624.3
Noncontrolling Interest [Member]
Net Income (Loss) Attributable to Noncontrolling Interest		$ 40	$ 31	$ 90	$ 65
Retained Earnings [Member]
Net Earnings Attributable to Procter & Gamble		$ 2,917	$ 2,745	$ 10,227	$ 9,138

[1] Basic net earnings per share and Diluted net earnings per share are calculated on Net earnings attributable to Procter & Gamble.

[2] Net earnings per share are calculated on Net earnings attributable to Procter & Gamble.